Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct 1;185(14):1219-26.
doi: 10.1503/cmaj.121368. Epub 2013 Apr 22.

Diagnosis and management of pancreatic cancer

Zaheer S Kanji, Steven Gallinger
Review

Diagnosis and management of pancreatic cancer

Zaheer S Kanji et al. CMAJ. .
No abstract available

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Diagnostic algorithm for pancreatic cancer. Laboratory investigations include a complete blood count (CBC), liver enzyme tests for biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests to monitor for new onset or worsening diabetes. A transabdominal ultrasound can be performed for patients presenting with jaundice or nonspecific abdominal pain, followed by computed tomography (CT) if suspicious for pancreatic cancer. Patients with contraindications to CT, intolerance to contrast or in whom resectability is questioned can undergo magnetic resonance imagining (MRI). Endoscopic retrograde cholangiopancreatography (ERCP) is not routinely used, but cytologic brushings for diagnosis can be taken in those with cholangitis and an unknown pancreatic mass, or with jaundice who are unfit for immediate surgery. Endoscopic ultrasound- or CT-guided biopsies are used when diagnosis is unclear after imaging, in unresectable cases before palliative treatment or before neoadjuvant treatment. *Painless jaundice, pain in the right–upper quadrant or epigastric pain, indigestion, early satiety, steatorrhea, weight loss, abdominal mass. Dashed lines indicate imaging modalities that can be contained but are not routinely necessary.
Figure 2:
Figure 2:
Treatment algorithm for pancreatic cancer.
See this image and copyright information in PMC

Similar articles

  • Pancreatic cancer.
    Yeo CJ, Cameron JL. Yeo CJ, et al. Curr Probl Surg. 1999 Feb;36(2):59-152. Curr Probl Surg. 1999. PMID: 10021685 Review. No abstract available.
  • Imaging of pancreatic adenocarcinoma: update on staging/resectability.
    Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Tamm EP, et al. Radiol Clin North Am. 2012 May;50(3):407-28. doi: 10.1016/j.rcl.2012.03.008. Epub 2012 Apr 6. Radiol Clin North Am. 2012. PMID: 22560689 Review.
  • Prognostic factors in ductal pancreatic cancer.
    Yeo CJ, Cameron JL. Yeo CJ, et al. Langenbecks Arch Surg. 1998 Apr;383(2):129-33. doi: 10.1007/s004230050104. Langenbecks Arch Surg. 1998. PMID: 9641885 Review.
  • [Current aspects of diagnosis and therapy of pancreatic carcinoma].
    Rosewicz S. Rosewicz S. Z Gastroenterol. 2002 Dec;40 Suppl 2:62-3. doi: 10.1055/s-2002-35889. Z Gastroenterol. 2002. PMID: 12467013 German. No abstract available.
  • Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
    Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA; National Comprehensive Cancer Networks. Tempero MA, et al. J Natl Compr Canc Netw. 2012 Jun 1;10(6):703-13. doi: 10.6004/jnccn.2012.0073. J Natl Compr Canc Netw. 2012. PMID: 22679115 Free PMC article.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Al-Sukhni W, Borgida A, Rothenmund H, et al. Screening for pancreatic cancer in a high risk cohort: an eight year experience. J GastroIntestinal Surg 2012;16:771–83 - PubMed
    1. Canadian Cancer Society’s Steering Committee on Cancer Statistics Canadian Cancer Statistics 2012. Toronto (ON): Canadian Cancer Society; 2012
    1. Woodmass J, Lipschitz J, McKay A. Physician attitudes and treatment of patterns for pancreatic cancer. World J Surg Oncol 2011;9:21. - PMC - PubMed
    1. Hidalgo M. Pancreas cancer. NEJM 2010;362:1605–17 - PubMed
    1. Pancreatic cancer survival by stage. Atlanta (GA): American Cancer Society; 2013. Available: www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-s... (accessed 2013 Mar. 21).

Publication types